300725.SZ
药石科技
SZSE · Healthcare · M 科研服务 · CN
CNY 48.31
−6.12%Margins
Gross margin
31.3%
EBITDA margin
17.4%
EBIT margin
11.1%
Net margin
9.7%
FCF margin
12.7%
3.6%
Return on equity
3.1%
Return on assets
4.0%
Return on invested capital
0.30x
Asset turnover
CNY 471.2M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026